New Arthritis Treatment Promises Good Results.

Many people are used to thinking of arthritis as of the disease prevailing in people over 60. It is incorrect. Elderly people are thought to be mostly affected by the disease because if they have not got proper treatment in time, arthritis manifestation is really dreadful.

Actually, depending on the type of arthritis, 35-45-year-old people are more often affected by the disease. There exists also juvenile arthritis, which manifests itself in young age. Now you have a notion of how important it is to diagnose arthritis in its early stages.

It's important to timely consult specialist of rheumatological centres. The specialists are experienced in the modern methods of arthritis treatment.

There is a new treatment option which gives hope to all, suffering from arthritis. The three biologicals so called antagonists TNF-alpha Etanercept, Adalimumab, Infliximab have already been present in the market for several years, and there exist results of long-run investigation of the preparations.

The most extensive study of rheumatoid arthritis, so called Re-Act study, was carried out with the assistance of 6000 patients of 4000 centers in 11 European countries. The results have been published only at the end of 2004.

Patients received a hypodermic injection of 40 mg of Adalimumab once in 2 weeks. In 12 weeks the results of treatment were explored and evaluated. The results were as follows: The results were amazing! Pain in joint when pressed reduced from 13% till 3%, e.g. in 77% of cases!!! 23% of patients did not suffer pain in joint when pressed.

Swelling in joints reduced from 10% till 3%, e.g. in 70% of cases!!!! 25% of patients marked disappearance of swelling in joints after12 weeks of the treatment. As early as after the first injection, 70% of the patients suffering pain in joints when pressed and 57% of the patients with join swelling pointed to the good results of the treatment.

One fourth of the patients marked the elimination of pain after 12 weeks of the treatment. Some further results of the Re-Act study showed further health improvement.

But the medicines are very costly. In Europe prescription of the medicines is under control and is in connection with the certain illness severity score. It is worth underlining once again that the preparations might have side actions and have to be prescribed by an experienced doctor.

Therapeutic effect of the basis medicines becomes apparent in 1-2 months, this of biologics - in several days (or weeks).